Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693173 · ClinicalTrials.gov registry record
Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients
A clinical trial of Anal Cancer, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT00693173 is a study of Anal Cancer that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 14 participants, below the 579-participant average among 19 other Anal Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00693173, a study of Anal Cancer, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The study compares two patient setups (Standard Prone vs. Genital Drop Technique) with identical radiation treatment technique and parameters. After the two setups have been planned, the treating faculty reviews the setups and will choose the setup he feels that will give the patient improved dosimetry to the local regions and hopefully reduce toxicity and improve treatment tolerability.
Conditions Studied
Study Locations (1)
Texas
- The University of Texas Medical Branch at Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693173
The ClinicalTrials.gov registry entry for NCT00693173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 19 other Anal Cancer trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00693173 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00693173 about?
NCT00693173 is a clinical study titled "Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients". The study compares two patient setups (Standard Prone vs. Genital Drop Technique) with identical radiation treatment technique and parameters. After the two setups have been planned, the treating faculty reviews the setups and will choose the setup he feels that will give the patient improved dosime...
What is the current status of trial NCT00693173?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2007-07. Estimated completion is 2009-06.
What conditions does trial NCT00693173 study?
This clinical trial studies the following conditions: Anal Cancer.
Who is sponsoring clinical trial NCT00693173?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00693173 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
RECRUITING
-
Self-sampling to Optimize Anal Lesion Outcomes
RECRUITING · NA
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
-
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
RECRUITING · Phase 2
-
Integrated Cancer Repository for Cancer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.